NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VC Cell Therapy

VC Cell Therapy

Private
KobeHealthcare & Life Scienceshttps://www.vcct.jp/

Last Round

VC Round

Nov 15, 2023

Total Funding Raised

$7.33M

Company Overview

VC Cell Therapy is a biotechnology company that develops regenerative cell therapies for retinal degeneration diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Infrastructure

Keywords

cell therapyinduced pluripotent stem cellsiPSCsregenerative medicineretinal degenerationallogeneic cell therapyoff-the-shelf cell therapyRPE cellsphotoreceptor cellsAge-related Macular DegenerationAMDRetinitis PigmentosaRPretinal organoidsautomated cell manufacturinggenome editingAI in manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VC Cell Therapy Comparables

Compare VC Cell Therapy with similar companies based on industry and business-model similarity.

VC Cell Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Regenerative Patch Technologies
79%
Eyestem Research
78%
jCyte, Inc.
76%

VC Cell Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 15, 2023
Convertible DebtApr 1, 2021

VC Cell Therapy Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2023

    $4M raised from YASKAWA Electric Corporation and others.

  • Apr 1, 2021

    Raised $5.33M in convertible debt.

VC Cell Therapy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VC Cell Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VC Cell Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersKobe
Employee Range3
Year Founded2021
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.